Navigation Links
PacificGMP Completes GMP Product Fill for Trius Therapeutics
Date:5/14/2008

SAN DIEGO, May 14 /PRNewswire/ -- PacificGMP, the leader in utilizing single-use bioprocessing for development and manufacturing for its client partners, announced today that it has completed a product fill under GMP (good manufacturing practices) standards for a Trius Therapeutics Phase I clinical trial.

"We are pleased to have worked closely with Trius on this GMP fill project, an effort that we were able to initiate quickly and complete within a narrow deadline," said Leigh N. Pierce, president of PacificGMP. "Although our client base consists of mainly biologics drug developers, PacificGMP has completed projects for a variety of other customers including small molecule drug developers like Trius, as well as academic institutions and diagnostics companies."

"PacificGMP successfully completed our GMP product fill and I appreciated their flexibility and willingness to work with us to get the job done in a timely and professional manner," said Jeffrey Barker, Director of Pharmaceutical Development for Trius Therapeutics.

About PacificGMP

PacificGMP is a contract manufacturing organization (CMO) and industry leader in utilizing single-use bioprocessing for development and manufacturing of biologics. Single-use technology eliminates the risk of cross-contamination, has fewer system requirements and significantly reduces the time required to initiate production. Benefits to clients include rapid project turnaround and the most cost effective solution in the industry. PacificGMP provides cGMP and non-GMP services ranging from cell line optimization, early process design, development and scale-up, to preclinical and clinical biologics manufacturing, purification and fill/finish. More information can be found by visiting the Company's web site at http://www.pacificGMP.com.

About Trius Therapeutics

Trius Therapeutics is discovering and developing innovative antibacterial
'/>"/>

SOURCE PacificGMP
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
7. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
8. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...., Dec. 1 nContact Surgical, Inc. ...ices for minimally-invasive treatment for heart co...ibility clinical trial designed to evaluate the sa...ter procedure, the convergent procedure, for the t...tion (AF). This prospective, feasibility study wi...
(Date:12/1/2009)...Dec. 1 Exagen Diagnostics, Inc., a...develops and markets proprietary genomic tests, to...airman of the company,s board of directors and chi...n, Glenn was managing partner of Windamere Venture...omedical companies including Prometheus Laboratori...
(Date:12/1/2009)..., Dec. 1 Tibotec Therapeutics, a d...announced today that it is launching a new initiat...nd people of color living with HIV/AIDS. Through a...l events, media outreach and a new Web site, www....gs from the GRACE study, the largest clinical tria...
Breaking Medicine Technology:nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Mayo Clinic physician receives first PASSOR Legacy Award 60163 1Poor in rural Oregon face double binds when getting food 10547 1Poor in rural Oregon face double binds when getting food 10547 2Poor in rural Oregon face double binds when getting food 10547 3Triple combo drug shows promise against antiviral resistant H1N1 UAB researcher says 10543 1Triple combo drug shows promise against antiviral resistant H1N1 UAB researcher says 10543 2
..., Dec. 6 Some 5,000 COPD patients will be tested,... Deficiency (Alpha-1) in,a study marking a major c...nd the American Association for Respiratory Care (...andhaus, MD, PhD, of the,Division of Pulmonary Med...,in Denver. Sandhaus is also the Clinical Director...
...SAN FRANCISCO, Calif., Dec. 6 Rigel,Pharmaceutica... corporate,partner, Pfizer (NYSE: PFE ), has begu...on of Rigel,s small molecule syk kinase inhibitor,...s the third product candidate,in Rigel,s clinical ...5 collaboration agreement, Rigel,will receive a $5...
Other Medicine Technology:Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
(Date:12/1/2009)..., , ADDISON, Texas, Dec. 1 F...hensive health care is more than just an employee ...ily of employees. Hobby Lobby Stores, Inc. is lead...ening a worksite health and wellness center at its...t health care services directly to employees and t...
(Date:12/1/2009)..., , MILWAUKEE, Dec. 1 /PRNew...eatest asset is the ability to earn an income. It ...possible to not only pay today,s mortgage but also...ement costs. ,, Yet, according to a Northwes...e 21 and over have taken measures to protect their...
(Date:12/1/2009)..., , Gay Men,s Health Crisis Encourages P...RK, Dec. 1 Today on Wor...ffirming its commitment to continue helping divers...DS, including people struggling with crystal metha... interactive crystal methamphetamine resource, ww...
(Date:12/1/2009)..., , LOS ANGELES, Dec. 1 ...s and Clementines kicks off its 2009/2010 growing ...he brand,s relationship with kids, soccer. Joy Fa...mom - will captain the brand,s efforts to celebrat...bined with league sponsorship expansion into Texas...
(Date:12/1/2009)...ng-lasting effects on brain seen by researchers us... (HealthDay News) -- Childhood exposure to lead ca...und. , "What we have found is that no region of...areas of the brain are affected differently," stud...nati Children,s Hospital Medical Center and a prof...
Breaking Medicine News(10 mins):Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 2Health News:Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 3Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 2Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4Health News:Childhood Lead Exposure Causes Permanent Damage: Study 2
...$7,million HIV infusion therapy scheme to defraud ..., seven months home confinement, and three years,s...e S. Fisher of the,Criminal Division and U.S. Atto...udge Patricia Seitz at the federal court in Miami....
...e in understanding the genetic processes that give...The knowledge could lead to a range of benefits, i...ng properties of plant pigments and new, natural f...he scientists, at the John Innes Centre and Instit...
...sing to Consider Proposals, SALINAS, Calif., Oct....s Northern California conducted simultaneous,infor...ployer,s,unwillingness to bargain over legitimate ...h hundreds of workers represented by SEIU United,H...
...evenues and,shrinking sales forces, pharmaceutical... Affairs, to maximize their sales support role, ye...this goal, leading pharmaceutical,companies run sl... Best Practices, LLC,s benchmarking report Medical...
...Association (ADA) House of Delegates called for th...nd the materials used to create dental fillings,an...f placement, durability,and relative costs of each...lets, the,association wants to ensure its availabi...
...tion of polyps and their removal during th...K BROOK, Ill., Oct. 2 According to the,American S...noscopy remains,the most effective screening optio...ughly evaluate the entire colon.,Colonoscopy has a...
Other Medicine News:Health News:Florida Doctor Sentenced to 18 Months in Prison for Medicare Fraud 2Health News:New research into plant colors sheds light on antioxidants 2Health News:Workers Hold Pickets For Right to Improve Care 2Health News:Medical Affairs: Building Efficient Medical Affairs Functions That Drive Product Marketing Success 2Health News:ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices 2Health News:Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2Health News:Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 3Health News:Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 4
... Holder provides precise control of the thigh duri..., and maximum exposure of the proximal thigh durin...r can be used on both right and left legs and may ...file Leg Holder can be used with an Arthrex tourni...
...extremity for prepping before hip or knee surgery....rticularly helpful for supporting the leg with the...lding the foot/ankle in an externally rotated posi...helps eliminate the need for manual support.,The...
...ixator is ideal for trauma, foot and ankle or defo... products ,True/Lok External Fixation compone...frame assembly and the complexity of intra-operati... modular, preassembled distractors and hinges elim...
Adjustable Leg Support Stand
Medicine Products: